“We’re sitting at the tip of our chair waiting for the phone call that the product will be approved,” Medtronic EVP and EMEA President Rob ten Hoedt said Friday.
Fridley, Minnesota-based Medtronic (NYSE:MDT) filed for European approval in March, starting a process that takes about six to nine months. Medtronic’s now “in shooting range,” ten Hoedt said.
Get the full story at our sister site, Medical Design & Outsourcing.